ClinConnect ClinConnect Logo
Search / Trial NCT05493046

Interactive Hand Exercise Game on Grip Strength and Vascular Maturation

Launched by TAIPEI MEDICAL UNIVERSITY · Aug 8, 2022

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Hand Grip Strength Hemodialysis

ClinConnect Summary

This clinical trial is studying a fun and interactive hand exercise game designed to improve grip strength and help the blood vessels mature in patients undergoing hemodialysis. Hemodialysis is a treatment for people with severe kidney problems, and it often requires a special surgical connection called an arteriovenous fistula. By using smart technology and engaging exercises, the goal is to make patients more motivated to participate in their rehabilitation and improve their overall health.

To participate in this trial, individuals need to be between 20 and 70 years old and have a diagnosis of chronic kidney failure, either before starting dialysis or after beginning hemodialysis with a newly created arteriovenous fistula. Participants should be able to communicate in Chinese and have clear awareness of their surroundings. However, those with certain conditions, like previous problems with their fistula or specific arm injuries, won’t be eligible. If you join this study, you can expect to engage in enjoyable exercises that could help strengthen your hand and potentially improve your treatment experience.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Clinical diagnosis of chronic renal failure stage 4 to 5 (before dialysis) and stage 5 (patients who have started hemodialysis).
  • Newly established surgical patients with autologous arteriovenous fistula.
  • Aged between 20 and 70 years old.
  • Having clear consciousness and being able to communicate in Chinese.
  • Exclusion Criteria:
  • Previous dysfunction of an autologous arteriovenous fistula in the same arm.
  • Injury to the fistula extremity.
  • Neuromusculoskeletal abnormalities.
  • Upper extremity arthritis.
  • Peripheral neuropathy.
  • Peripheral arterial dysfunction.
  • Venous disease.
  • Rheumatic disease.

About Taipei Medical University

Taipei Medical University (TMU) is a leading educational and research institution located in Taipei, Taiwan, dedicated to advancing health sciences and clinical research. Established with a focus on fostering innovation in medical education, TMU integrates comprehensive clinical training with rigorous research methodologies. The university is committed to improving patient outcomes through a strong emphasis on translational medicine and interdisciplinary collaboration. TMU's clinical trial initiatives are designed to explore new treatments and therapies, contributing to the global body of medical knowledge while adhering to the highest ethical standards and regulatory compliance.

Locations

Taipei, , Taiwan

Patients applied

0 patients applied

Trial Officials

Chiu Hsiao-Yean, PhD

Principal Investigator

Taipei Medical University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials